Pediatric and adult MS: a longitudinal multimodal MRI study to explore the substrates of the different clinical courses
Author(s): ,
E. De Meo
Affiliations:
Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience; Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan
,
A. Meani
Affiliations:
Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience
,
L. Moiola
Affiliations:
Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan
,
B. Colombo
Affiliations:
Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan
,
M. Rodegher
Affiliations:
Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan
,
A. Ghezzi
Affiliations:
Multiple Sclerosis Study Center, ASST Valle Olona, Gallarate Hospital, Gallarate
,
G. Comi
Affiliations:
Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan
,
A. Falini
Affiliations:
Department of Neuroradiology and CERMAC, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
,
M. Filippi
Affiliations:
Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience; Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan
M.A. Rocca
Affiliations:
Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience; Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan
ECTRIMS Online Library. De Meo E. Oct 12, 2018; 228964; P1124
Ermelinda De Meo
Ermelinda De Meo
Contributions
Abstract

Abstract: P1124

Type: Poster Sessions

Abstract Category: Pathology and pathogenesis of MS - MRI and PET

Background: At short-medium term, pediatric multiple sclerosis (MS) patients have a more favorable clinical course than adult ones. However, only a few studies have investigated the pathobiological basis of such a different clinical outcome. Against this background we aimed at exploring structural and functional MRI substrates underlying clinical differences between pediatric and adult MS patients.
Methods: Using a 3T scanner, brain dual-echo, 3DT1-weighted and resting state (RS) functional MRI (fMRI) scans were acquired from 31 pediatric (pedMS) and 30 adult MS (adMS) patients at baseline and after a mean follow-up of 3.2 years. Twenty-six pediatric and 30 adult healthy controls (HC) were also enrolled. Voxel-based and tensor-based morphometry were used to assess patterns of gray matter (GM) volume and their modifications, while RS functional connectivity (FC) was evaluated using independent component analysis. Correlations between MRI and clinical variables were explored using multiple regression models.
Results: At baseline, excluding age-related differences, compared to adMS, pedMS patients showed higher volumes of temporal, parietal and occipital regions. During the follow-up, compared to adMS, pedMS showed more significant GM atrophy in several frontal and parietal regions, with sparing of bilateral cerebellum and postcentral gyrus, left middle frontal gyrus and supplementary motor area. Both at baseline and follow-up, compared to adMS, pedMS showed brain regions with increased and decreased RS FC in default mode network, sensorimotor network, executive control network and salience network. During the follow-up, EDSS remained stable in pedMS and worsened in adMS. EDSS changes in adMS were correlated with RS FC modifications, but not with GM volume changes.
Conclusions: The onset of MS during childhood is likely to increase vulnerability to neurodegenerative processes, especially for brain regions with a maturation during adolescence. Functional brain plasticity is likely to protect pedMS patients from clinical disability accrual.
Funding: Partially supported by Italian Ministry of Health (GR-2009-1529671) and Fondazione Italiana Sclerosi Multipla (FISM2011/R/19, FISM 2012/R/8, FISM-2016-R-23)
Disclosure: E. De Meo, A. Meani, L. Moiola, B. Colombo, M. Rodegher, and A. Falini have nothing to disclose.
A. Ghezzi received honoraria for speaking from Biogen-Idec, Merck-Serono, Novartis, Genzyme, Teva, and Allergan, and for consultancy from Merck-Serono, Teva, Novartis, and Biogen-Idec; and received support for participation in national and international congresses from Schering, Biogen-Idec, Merck-Serono, Novartis, Genzyme, and Teva.
G. Comi has received consulting fees for participating on advisory boards from Novartis, Teva Pharmaceutical Ind. Ltd, Sanofi, Genzyme, Merck Serono, Bayer, Actelion and honorarium for speaking activities for Novartis, Teva Pharmaceutical Ind. Ltd, Sanofi, Genzyme, Merck Serono, Bayer, Biogen, ExceMED.
M. Filippi is Editor-in-Chief of the Journal of Neurology; received compensation for consulting services and/or speaking activities from Biogen Idec, Merck-Serono, Novartis, Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Teva Pharmaceutical Industries, Roche, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
M.A. Rocca received speakers honoraria from Biogen Idec, Novartis, Genzyme, Sanofi-Aventis, Teva, Merck Serono, and Roche and receives research support from the Italian Ministry of Health and Fondazione Italiana Sclerosi Multipla.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies